Isoflurane Alters the Amount of Dopamine Transporter Expressed on the Plasma Membrane in Humans

Background:Isoflurane increases extracellular dopamine concentration and causes trafficking of the dopamine transporter (DAT) in transfected cells. Also, the binding potentials of highly specific positron-emitting DAT ligands are altered by isoflurane in rhesus monkeys. The purpose of this study was to determine the dose–response curve for isoflurane altering the binding potential of one of these ligands ([F-18]FECNT) in humans. Methods:Twenty human volunteers underwent positron emission tomography using [F-18]FECNT. All subjects were scanned while awake and then again after assignment to one of four groups (n = 5 each): awake-control, propofol-control, or light or deep isoflurane anesthesia as defined by Bispectral Index monitoring. Bispectral Index values in the light anesthesia group were 40 ± 7 (end-tidal isoflurane, 1.02 ± 0.08) versus 27 ± 10 (end-tidal isoflurane, 1.6 ± 0.3) in the deep anesthesia group. The within-subject percent change in putamen binding potential between the awake and second scans was determined for each subject, averaged within groups, and compared across groups. Results:The [F-18]FECNT binding potential exhibited a biphasic shape as a function of anesthetic dose. The binding potential for the second scan in the awake-control and propofol-control groups was significantly less than the initial scan; for the light anesthesia group, the binding potential was significantly increased during anesthesia, and no change was detected between the two scans in the deeper anesthesia group. Conclusion:Isoflurane causes a dose-dependent change in the [F-18]FECNT binding potential for DAT consistent with isoflurane causing trafficking of the DAT between the plasma membrane and the cell interior. Concentrations of isoflurane below minimum alveolar concentration causes DAT to be trafficked to the plasma membrane from the cell interior, but no net trafficking occurs at higher concentrations. The data are most easily explained if isoflurane alters the amount of functionally expressed DAT through an indirect pathway. This phenomena should be more fully explored to help make the next generation of anesthetics more mechanistically specific and to reduce undesired side effects.

[1]  J. Fallon,et al.  Monoamine Innervation of Cerebral Cortex and a Theory of the Role of Monoamines in Cerebral Cortex and Basal Ganglia , 1932 .

[2]  C. D. Richards,et al.  The actions of volatile anaesthetics on synaptic transmission in the dentate gyrus. , 1975, The Journal of physiology.

[3]  B. Berger,et al.  Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine‐beta‐hydroxylase , 1989, The Journal of comparative neurology.

[4]  [The effect of sevoflurane and isoflurane on striatal dopamine of awake freely moving rats observed in an in vivo microdialysis study]. , 1999, Masui. The Japanese journal of anesthesiology.

[5]  J. Votaw,et al.  Self‐administration of cocaine and the cocaine analog RTI‐113: Relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys , 2002, Synapse.

[6]  John Votaw,et al.  Interaction of Isoflurane with the Dopamine Transporter , 2003, Anesthesiology.

[7]  J. Mantz,et al.  Effects of Volatile Anesthetics, Thiopental, and Ketamine on Spontaneous and Depolarizationevoked Dopamine Release from Striatal Synaptosomes in the Rat , 1994, Anesthesiology.

[8]  Hideo Tsukada,et al.  Dose–response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis , 2000, Brain Research.

[9]  W. J. Russell,et al.  The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. , 1975, The Journal of physiology.

[10]  R. Eckenhoff,et al.  Inhalation anaesthetic competition at high-affinity cocaine binding sites in rat brain synaptosomes. , 1994, British journal of anaesthesia.

[11]  J. Mantz,et al.  Halothane and Isoflurane Differentially Affect the Regulation of Dopamine and Gamma‐aminobutyric Acid Release Mediated by Presynaptic Acetylcholine Receptors in the Rat Striatum , 1997, Anesthesiology.

[12]  R. Eckenhoff,et al.  Inhibition of Dopamine Transport in Rat Brain Synaptosomes by Volatile Anesthetics , 1993, Anesthesiology.

[13]  E. Mignot,et al.  Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of d- and l-derivatives in canine narcolepsy , 2000, Neuroscience.

[14]  L. Firestone,et al.  Staurosporine, a Protein Kinase C Inhibitor, Decreases the General Anesthetic Requirement in Rana pipiens Tadpoles , 1993, Anesthesia and analgesia.

[15]  M. Reith,et al.  In vivo microdialysis for measurement of extracellular monoamine levels following inhibition of monoamine transporters. , 1998, Methods in enzymology.

[16]  I. Sora,et al.  Dopaminergic Role in Stimulant-Induced Wakefulness , 2001, The Journal of Neuroscience.

[17]  E. Ryding,et al.  Distribution of Cerebral Blood Flow during Anesthesia with Isoflurane or Halothane in Humans , 1995, Anesthesiology.

[18]  R. Depue,et al.  Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. , 1998, Cerebral cortex.

[19]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  C. Kilts,et al.  18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. , 2000, Nuclear medicine and biology.

[21]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[22]  L. Howell,et al.  Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. , 1991, The Journal of pharmacology and experimental therapeutics.

[23]  K. Morita,et al.  Effects of volatile and intravenous anesthetics on the uptake of GABA, glutamate and dopamine by their transporters heterologously expressed in COS cells and in rat brain synaptosomes. , 2001, Toxicology letters.

[24]  G. Knudsen,et al.  Interference of anaesthetics with radioligand binding in neuroreceptor studies , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  J. Votaw,et al.  Isoflurane induces dopamine transporter trafficking into the cell cytoplasm , 2004, Synapse.

[26]  P. Goldman-Rakic.  The cortical dopamine system: role in memory and cognition. , 1998, Advances in pharmacology.

[27]  Hideo Tsukada,et al.  Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain , 1999, Brain Research.

[28]  Biodistribution and radiation dosimetry of the dopamine transporter ligand. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Shitij Kapur,et al.  Anesthetics inhibit high‐affinity states of dopamine D2 and other G‐linked receptors , 2003, Synapse.

[30]  A. Fink-Jensen,et al.  Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  R. Gainetdinov,et al.  Cocaine self-administration in dopamine-transporter knockout mice , 1998, Nature Neuroscience.

[32]  C. Berridge,et al.  Wake-Promoting Actions of Dopamine D1 and D2 Receptor Stimulation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[33]  D. Haydon,et al.  The effects of some inhalation anaesthetics on the sodium current of the squid giant axon. , 1983, The Journal of physiology.

[34]  M. Kuhar,et al.  Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. , 2000, The Journal of pharmacology and experimental therapeutics.

[35]  John M Hoffman,et al.  Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F‐18]FECNT , 2002, Synapse.

[36]  Scott T Grafton,et al.  Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.